HIV and Osteoporosis

Todd T. Brown, Michael T. Yin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

With the availability of effective antiretroviral therapy (ART) in the mid-1990s, HIV has been transformed from a fatal disease into a manageable chronic illness in many parts of the world. Prior to this, HIV ranked among the most significant sources of morbidity and mortality among young people in the US. With current ART, sometimes referred to as highly active antiretroviral therapy (HAART), life expectancy among HIV-infected people is approaching that of their HIV-uninfected peers. Nevertheless, even with the availability of increasingly less toxic and less cumbersome therapies, an important survival gap remains between HIV-infected and -uninfected people.

Original languageEnglish (US)
Title of host publicationOsteoporosis
Subtitle of host publicationFourth Edition
PublisherElsevier Inc.
Pages1305-1329
Number of pages25
ISBN (Print)9780124158535
DOIs
StatePublished - Jun 2013

Keywords

  • Aging
  • Antiretroviral therapy (ART)
  • Bone mineral density (BMD)
  • Human immunodeficiency virus (HIV)
  • Lean body mass
  • Osteoporosis
  • Vitamin D deficiency

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'HIV and Osteoporosis'. Together they form a unique fingerprint.

Cite this